 | • レポートコード：GIR-107A11942 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、T細胞療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。T細胞療法の種類別市場規模（CAR T細胞療法、TCR療法、TIL療法）、用途別市場規模（病院、クリニック・外来センター、がん研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・T細胞療法の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Gilead Sciences, Inc.、Sorrento Therapeutics、Fate Therapeutics Inc.、Novartis International AG、AbbVie Inc.、Adaptimmune Therapeutics PLC、Bluebird Bio、TCR2 Therapeutics, Inc.、Pfizer Inc.、DiaCarta, Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：CAR T細胞療法、TCR療法、TIL療法 ・用途別分析2016年-2026年：病院、クリニック・外来センター、がん研究所、その他 ・T細胞療法の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・T細胞療法のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・T細胞療法のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・T細胞療法の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・T細胞療法の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The T-Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global T-Cell Therapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global T-Cell Therapy market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
T-Cell Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
CAR T Cell Therapy
TCR Therapy
TIL Therapy
Market segment by Application, can be divided into
Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others
Market segment by players, this report covers
Gilead Sciences, Inc.
Sorrento Therapeutics
Fate Therapeutics Inc.
Novartis International AG
AbbVie Inc.
Adaptimmune Therapeutics PLC
Bluebird Bio
TCR2 Therapeutics, Inc.
Pfizer Inc.
DiaCarta, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe T-Cell Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of T-Cell Therapy, with revenue, gross margin and global market share of T-Cell Therapy from 2019 to 2021.
Chapter 3, the T-Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and T-Cell Therapy market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe T-Cell Therapy research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of T-Cell Therapy
1.2 Classification of T-Cell Therapy by Type
1.2.1 Overview: Global T-Cell Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global T-Cell Therapy Revenue Market Share by Type in 2020
1.2.3 CAR T Cell Therapy
1.2.4 TCR Therapy
1.2.5 TIL Therapy
1.3 Global T-Cell Therapy Market by Application
1.3.1 Overview: Global T-Cell Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics & Ambulatory Centers
1.3.4 Cancer Research Institutes
1.3.5 Others
1.4 Global T-Cell Therapy Market Size & Forecast
1.5 Global T-Cell Therapy Market Size and Forecast by Region
1.5.1 Global T-Cell Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global T-Cell Therapy Market Size by Region, (2016-2021)
1.5.3 North America T-Cell Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe T-Cell Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific T-Cell Therapy Market Size and Prospect (2016-2026)
1.5.6 South America T-Cell Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa T-Cell Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 T-Cell Therapy Market Drivers
1.6.2 T-Cell Therapy Market Restraints
1.6.3 T-Cell Therapy Trends Analysis
2 Company Profiles
2.1 Gilead Sciences, Inc.
2.1.1 Gilead Sciences, Inc. Details
2.1.2 Gilead Sciences, Inc. Major Business
2.1.3 Gilead Sciences, Inc. T-Cell Therapy Product and Solutions
2.1.4 Gilead Sciences, Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Gilead Sciences, Inc. Recent Developments and Future Plans
2.2 Sorrento Therapeutics
2.2.1 Sorrento Therapeutics Details
2.2.2 Sorrento Therapeutics Major Business
2.2.3 Sorrento Therapeutics T-Cell Therapy Product and Solutions
2.2.4 Sorrento Therapeutics T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Sorrento Therapeutics Recent Developments and Future Plans
2.3 Fate Therapeutics Inc.
2.3.1 Fate Therapeutics Inc. Details
2.3.2 Fate Therapeutics Inc. Major Business
2.3.3 Fate Therapeutics Inc. T-Cell Therapy Product and Solutions
2.3.4 Fate Therapeutics Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Fate Therapeutics Inc. Recent Developments and Future Plans
2.4 Novartis International AG
2.4.1 Novartis International AG Details
2.4.2 Novartis International AG Major Business
2.4.3 Novartis International AG T-Cell Therapy Product and Solutions
2.4.4 Novartis International AG T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Novartis International AG Recent Developments and Future Plans
2.5 AbbVie Inc.
2.5.1 AbbVie Inc. Details
2.5.2 AbbVie Inc. Major Business
2.5.3 AbbVie Inc. T-Cell Therapy Product and Solutions
2.5.4 AbbVie Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 AbbVie Inc. Recent Developments and Future Plans
2.6 Adaptimmune Therapeutics PLC
2.6.1 Adaptimmune Therapeutics PLC Details
2.6.2 Adaptimmune Therapeutics PLC Major Business
2.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Product and Solutions
2.6.4 Adaptimmune Therapeutics PLC T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Adaptimmune Therapeutics PLC Recent Developments and Future Plans
2.7 Bluebird Bio
2.7.1 Bluebird Bio Details
2.7.2 Bluebird Bio Major Business
2.7.3 Bluebird Bio T-Cell Therapy Product and Solutions
2.7.4 Bluebird Bio T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Bluebird Bio Recent Developments and Future Plans
2.8 TCR2 Therapeutics, Inc.
2.8.1 TCR2 Therapeutics, Inc. Details
2.8.2 TCR2 Therapeutics, Inc. Major Business
2.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Product and Solutions
2.8.4 TCR2 Therapeutics, Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 TCR2 Therapeutics, Inc. Recent Developments and Future Plans
2.9 Pfizer Inc.
2.9.1 Pfizer Inc. Details
2.9.2 Pfizer Inc. Major Business
2.9.3 Pfizer Inc. T-Cell Therapy Product and Solutions
2.9.4 Pfizer Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Pfizer Inc. Recent Developments and Future Plans
2.10 DiaCarta, Inc.
2.10.1 DiaCarta, Inc. Details
2.10.2 DiaCarta, Inc. Major Business
2.10.3 DiaCarta, Inc. T-Cell Therapy Product and Solutions
2.10.4 DiaCarta, Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 DiaCarta, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global T-Cell Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 T-Cell Therapy Players Market Share
3.2.2 Top 10 T-Cell Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 T-Cell Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global T-Cell Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global T-Cell Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global T-Cell Therapy Revenue Market Share by Application (2016-2021)
5.2 T-Cell Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America T-Cell Therapy Revenue by Type (2016-2026)
6.2 North America T-Cell Therapy Revenue by Application (2016-2026)
6.3 North America T-Cell Therapy Market Size by Country
6.3.1 North America T-Cell Therapy Revenue by Country (2016-2026)
6.3.2 United States T-Cell Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada T-Cell Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico T-Cell Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe T-Cell Therapy Revenue by Type (2016-2026)
7.2 Europe T-Cell Therapy Revenue by Application (2016-2026)
7.3 Europe T-Cell Therapy Market Size by Country
7.3.1 Europe T-Cell Therapy Revenue by Country (2016-2026)
7.3.2 Germany T-Cell Therapy Market Size and Forecast (2016-2026)
7.3.3 France T-Cell Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom T-Cell Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia T-Cell Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy T-Cell Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific T-Cell Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific T-Cell Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific T-Cell Therapy Market Size by Region
8.3.1 Asia-Pacific T-Cell Therapy Revenue by Region (2016-2026)
8.3.2 China T-Cell Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan T-Cell Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea T-Cell Therapy Market Size and Forecast (2016-2026)
8.3.5 India T-Cell Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia T-Cell Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia T-Cell Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America T-Cell Therapy Revenue by Type (2016-2026)
9.2 South America T-Cell Therapy Revenue by Application (2016-2026)
9.3 South America T-Cell Therapy Market Size by Country
9.3.1 South America T-Cell Therapy Revenue by Country (2016-2026)
9.3.2 Brazil T-Cell Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina T-Cell Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa T-Cell Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa T-Cell Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa T-Cell Therapy Market Size by Country
10.3.1 Middle East & Africa T-Cell Therapy Revenue by Country (2016-2026)
10.3.2 Turkey T-Cell Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia T-Cell Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE T-Cell Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global T-Cell Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global T-Cell Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market T-Cell Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global T-Cell Therapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global T-Cell Therapy Revenue Market Share by Region (2021-2026)
Table 6. Gilead Sciences, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Gilead Sciences, Inc. Major Business
Table 8. Gilead Sciences, Inc. T-Cell Therapy Product and Solutions
Table 9. Gilead Sciences, Inc. T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Sorrento Therapeutics Corporate Information, Head Office, and Major Competitors
Table 11. Sorrento Therapeutics Major Business
Table 12. Sorrento Therapeutics T-Cell Therapy Product and Solutions
Table 13. Sorrento Therapeutics T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Fate Therapeutics Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Fate Therapeutics Inc. Major Business
Table 16. Fate Therapeutics Inc. T-Cell Therapy Product and Solutions
Table 17. Fate Therapeutics Inc. T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Novartis International AG Corporate Information, Head Office, and Major Competitors
Table 19. Novartis International AG Major Business
Table 20. Novartis International AG T-Cell Therapy Product and Solutions
Table 21. Novartis International AG T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. AbbVie Inc. Corporate Information, Head Office, and Major Competitors
Table 23. AbbVie Inc. Major Business
Table 24. AbbVie Inc. T-Cell Therapy Product and Solutions
Table 25. AbbVie Inc. T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Adaptimmune Therapeutics PLC Corporate Information, Head Office, and Major Competitors
Table 27. Adaptimmune Therapeutics PLC Major Business
Table 28. Adaptimmune Therapeutics PLC T-Cell Therapy Product and Solutions
Table 29. Adaptimmune Therapeutics PLC T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Bluebird Bio Corporate Information, Head Office, and Major Competitors
Table 31. Bluebird Bio Major Business
Table 32. Bluebird Bio T-Cell Therapy Product and Solutions
Table 33. Bluebird Bio T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. TCR2 Therapeutics, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. TCR2 Therapeutics, Inc. Major Business
Table 36. TCR2 Therapeutics, Inc. T-Cell Therapy Product and Solutions
Table 37. TCR2 Therapeutics, Inc. T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Pfizer Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Pfizer Inc. Major Business
Table 40. Pfizer Inc. T-Cell Therapy Product and Solutions
Table 41. Pfizer Inc. T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. DiaCarta, Inc. Corporate Information, Head Office, and Major Competitors
Table 43. DiaCarta, Inc. Major Business
Table 44. DiaCarta, Inc. T-Cell Therapy Product and Solutions
Table 45. DiaCarta, Inc. T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global T-Cell Therapy Revenue (USD Million) by Players (2019-2021)
Table 47. Global T-Cell Therapy Revenue Share by Players (2019-2021)
Table 48. Breakdown of T-Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. T-Cell Therapy Players Head Office, Products and Services Provided
Table 50. T-Cell Therapy Mergers & Acquisitions in the Past Five Years
Table 51. T-Cell Therapy New Entrants and Expansion Plans
Table 52. Global T-Cell Therapy Revenue (USD Million) by Type (2016-2021)
Table 53. Global T-Cell Therapy Revenue Share by Type (2016-2021)
Table 54. Global T-Cell Therapy Revenue Forecast by Type (2021-2026)
Table 55. Global T-Cell Therapy Revenue by Application (2016-2021)
Table 56. Global T-Cell Therapy Revenue Forecast by Application (2021-2026)
Table 57. North America T-Cell Therapy Revenue by Type (2016-2021) & (USD Million)
Table 58. North America T-Cell Therapy Revenue by Type (2021-2026) & (USD Million)
Table 59. North America T-Cell Therapy Revenue by Application (2016-2021) & (USD Million)
Table 60. North America T-Cell Therapy Revenue by Application (2021-2026) & (USD Million)
Table 61. North America T-Cell Therapy Revenue by Country (2016-2021) & (USD Million)
Table 62. North America T-Cell Therapy Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe T-Cell Therapy Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe T-Cell Therapy Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe T-Cell Therapy Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe T-Cell Therapy Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe T-Cell Therapy Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe T-Cell Therapy Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific T-Cell Therapy Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific T-Cell Therapy Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific T-Cell Therapy Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific T-Cell Therapy Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific T-Cell Therapy Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific T-Cell Therapy Revenue by Region (2021-2026) & (USD Million)
Table 75. South America T-Cell Therapy Revenue by Type (2016-2021) & (USD Million)
Table 76. South America T-Cell Therapy Revenue by Type (2021-2026) & (USD Million)
Table 77. South America T-Cell Therapy Revenue by Application (2016-2021) & (USD Million)
Table 78. South America T-Cell Therapy Revenue by Application (2021-2026) & (USD Million)
Table 79. South America T-Cell Therapy Revenue by Country (2016-2021) & (USD Million)
Table 80. South America T-Cell Therapy Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa T-Cell Therapy Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa T-Cell Therapy Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa T-Cell Therapy Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa T-Cell Therapy Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa T-Cell Therapy Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa T-Cell Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. T-Cell Therapy Picture
Figure 2. Global T-Cell Therapy Revenue Market Share by Type in 2020
Figure 3. CAR T Cell Therapy
Figure 4. TCR Therapy
Figure 5. TIL Therapy
Figure 6. T-Cell Therapy Revenue Market Share by Application in 2020
Figure 7. Hospitals Picture
Figure 8. Clinics & Ambulatory Centers Picture
Figure 9. Cancer Research Institutes Picture
Figure 10. Others Picture
Figure 11. Global T-Cell Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global T-Cell Therapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global T-Cell Therapy Revenue Market Share by Region (2016-2026)
Figure 14. Global T-Cell Therapy Revenue Market Share by Region in 2020
Figure 15. North America T-Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe T-Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific T-Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America T-Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa T-Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. T-Cell Therapy Market Drivers
Figure 21. T-Cell Therapy Market Restraints
Figure 22. T-Cell Therapy Market Trends
Figure 23. Gilead Sciences, Inc. Recent Developments and Future Plans
Figure 24. Sorrento Therapeutics Recent Developments and Future Plans
Figure 25. Fate Therapeutics Inc. Recent Developments and Future Plans
Figure 26. Novartis International AG Recent Developments and Future Plans
Figure 27. AbbVie Inc. Recent Developments and Future Plans
Figure 28. Adaptimmune Therapeutics PLC Recent Developments and Future Plans
Figure 29. Bluebird Bio Recent Developments and Future Plans
Figure 30. TCR2 Therapeutics, Inc. Recent Developments and Future Plans
Figure 31. Pfizer Inc. Recent Developments and Future Plans
Figure 32. DiaCarta, Inc. Recent Developments and Future Plans
Figure 33. Global T-Cell Therapy Revenue Share by Players in 2020
Figure 34. T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players T-Cell Therapy Revenue Market Share in 2020
Figure 36. Global Top 10 Players T-Cell Therapy Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global T-Cell Therapy Revenue Share by Type in 2020
Figure 39. Global T-Cell Therapy Market Share Forecast by Type (2021-2026)
Figure 40. Global T-Cell Therapy Revenue Share by Application in 2020
Figure 41. Global T-Cell Therapy Market Share Forecast by Application (2021-2026)
Figure 42. North America T-Cell Therapy Sales Market Share by Type (2016-2026)
Figure 43. North America T-Cell Therapy Sales Market Share by Application (2016-2026)
Figure 44. North America T-Cell Therapy Revenue Market Share by Country (2016-2026)
Figure 45. United States T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe T-Cell Therapy Sales Market Share by Type (2016-2026)
Figure 49. Europe T-Cell Therapy Sales Market Share by Application (2016-2026)
Figure 50. Europe T-Cell Therapy Revenue Market Share by Country (2016-2026)
Figure 51. Germany T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific T-Cell Therapy Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific T-Cell Therapy Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific T-Cell Therapy Revenue Market Share by Region (2016-2026)
Figure 59. China T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America T-Cell Therapy Sales Market Share by Type (2016-2026)
Figure 66. South America T-Cell Therapy Sales Market Share by Application (2016-2026)
Figure 67. South America T-Cell Therapy Revenue Market Share by Country (2016-2026)
Figure 68. Brazil T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa T-Cell Therapy Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa T-Cell Therapy Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa T-Cell Therapy Revenue Market Share by Country (2016-2026)
Figure 73. Turkey T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE T-Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の細胞治療バイオプロセシング市場 2021：企業別、地域別、種類・用途別 The Cell Therapy Bioprocessing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…- 世界の養子細胞療法市場 2021：企業別、地域別、種類・用途別 The Adoptive Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界のTCR-T治療試薬市場 2021：企業別、地域別、種類・用途別 The TCR-T Therapy Reagent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界のα1アンチトリプシン欠乏症増強療法市場 2021：企業別、地域別、種類・用途別 The Alpha-1 Antitrypsin Deficiency Augmentation Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- 世界のRFマイクロニードリング療法市場 2021：企業別、地域別、種類・用途別 The RF Microneedling Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…